Psychiatric Drug Discovery and Development, Princeton, NJ, USA, June 23-24, 2003.
Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA. alexander.scriabine@snet.net
Alexander
A
Scriabine
D000818:Animals; D014150:Antipsychotic Agents / Q000737:chemistry / Q000627:therapeutic use*; D015259:Dopamine Agents / Q000737:chemistry; D023281:Genomics; D009479:Neuropeptides / Q000737:chemistry; D011613:Psychotherapy; D011618:Psychotic Disorders / Q000188:drug therapy / Q000628:therapy*; D015203:Reproducibility of Results; D018490:Serotonin Agents / Q000737:chemistry
D014150:Antipsychotic Agents; D015259:Dopamine Agents; D009479:Neuropeptides; D018490:Serotonin Agents